Protocol: Remote care as the 'new normal'? Multi-site case study in UK general practice.

Remote consultations access digital inclusion e-consultations general practice telephone consultations triage video consultations

Journal

NIHR open research
ISSN: 2633-4402
Titre abrégé: NIHR Open Res
Pays: England
ID NLM: 9918333281906676

Informations de publication

Date de publication:
2022
Historique:
accepted: 22 07 2022
medline: 8 8 2022
pubmed: 8 8 2022
entrez: 26 10 2023
Statut: epublish

Résumé

Following a pandemic-driven shift to remote service provision, UK general practices offer telephone, video or online consultation options alongside face-to-face. This study explores practices' varied experiences over time as they seek to establish remote forms of accessing and delivering care. This protocol is for a mixed-methods multi-site case study with co-design and national stakeholder engagement. 11 general practices were selected for diversity in geographical location, size, demographics, ethos, and digital maturity. Each practice has a researcher-in-residence whose role is to become familiar with its context and activity, follow it longitudinally for two years using interviews, public-domain documents and ethnography, and support improvement efforts. Research team members meet regularly to compare and contrast across cases. Practice staff are invited to join online learning events. Patient representatives work locally within their practice patient involvement groups as well as joining an online patient learning set or linking via a non-digital buddy system. NHS Research Ethics Approval has been granted. Governance includes a diverse independent advisory group with lay chair. We also have policy in-reach (national stakeholders sit on our advisory group) and outreach (research team members sit on national policy working groups). We expect to produce rich narratives of contingent change over time, addressing cross-cutting themes including access, triage and capacity; digital and wider inequities; quality and safety of care (e.g. continuity, long-term condition management, timely diagnosis, complex needs); workforce and staff wellbeing (including non-clinical staff, students and trainees); technologies and digital infrastructure; patient perspectives; and sustainability (e.g. carbon footprint). By using case study methods focusing on depth and detail, we hope to explain why digital solutions that work well in one practice do not work at all in another. We plan to inform policy and service development through inter-sectoral network-building, stakeholder workshops and topic-focused policy briefings. The pandemic required general practices to introduce remote (phone, video and email) consultations. That policy undoubtedly saved lives at the time but there are also clear benefits of face-to-face consultations in some circumstances, and the exact role of remote care still needs to be worked out. Despite best efforts, remote care tends to worsen health inequities (people who were poor or less well educated are less able to access and navigate the system and secure the type of appointment they need or prefer). Workstream 1: We will look at 11 GP surgeries across England, Scotland and Wales. We have selected a variety of sites: urban and rural, serving a range of different communities. Each surgery has a different approach to technology. A researcher from our team will work alongside surgery staff to learn what methods and technologies each practice uses to deliver care. They will gather information (mostly qualitative) about how different technological solutions are playing out over time. Workstream 2: Many people experience barriers to accessing care when it is done through technology. This could be because they lack understanding of how to do it, don’t have the right equipment, can’t afford data, or other reasons. We will ask patients about their experiences and work with them and staff to develop ideas about how to overcome barriers. Workstream 3: We will take what we have learnt in Workstreams 1 and 2 to make suggestions to inform national stakeholders and to influence policymakers. Patients and members of the public helped shape the research design. They continue to help guide our research by reading our reports, giving us their opinions and advising on how best to share our research so everyone can benefit from what we have learnt. Our governance panel is chaired by a member of the public.

Sections du résumé

Background UNASSIGNED
Following a pandemic-driven shift to remote service provision, UK general practices offer telephone, video or online consultation options alongside face-to-face. This study explores practices' varied experiences over time as they seek to establish remote forms of accessing and delivering care.
Methods UNASSIGNED
This protocol is for a mixed-methods multi-site case study with co-design and national stakeholder engagement. 11 general practices were selected for diversity in geographical location, size, demographics, ethos, and digital maturity. Each practice has a researcher-in-residence whose role is to become familiar with its context and activity, follow it longitudinally for two years using interviews, public-domain documents and ethnography, and support improvement efforts. Research team members meet regularly to compare and contrast across cases. Practice staff are invited to join online learning events. Patient representatives work locally within their practice patient involvement groups as well as joining an online patient learning set or linking via a non-digital buddy system. NHS Research Ethics Approval has been granted. Governance includes a diverse independent advisory group with lay chair. We also have policy in-reach (national stakeholders sit on our advisory group) and outreach (research team members sit on national policy working groups).
Results anticipated UNASSIGNED
We expect to produce rich narratives of contingent change over time, addressing cross-cutting themes including access, triage and capacity; digital and wider inequities; quality and safety of care (e.g. continuity, long-term condition management, timely diagnosis, complex needs); workforce and staff wellbeing (including non-clinical staff, students and trainees); technologies and digital infrastructure; patient perspectives; and sustainability (e.g. carbon footprint).
Conclusion UNASSIGNED
By using case study methods focusing on depth and detail, we hope to explain why digital solutions that work well in one practice do not work at all in another. We plan to inform policy and service development through inter-sectoral network-building, stakeholder workshops and topic-focused policy briefings.
The pandemic required general practices to introduce remote (phone, video and email) consultations. That policy undoubtedly saved lives at the time but there are also clear benefits of face-to-face consultations in some circumstances, and the exact role of remote care still needs to be worked out. Despite best efforts, remote care tends to worsen health inequities (people who were poor or less well educated are less able to access and navigate the system and secure the type of appointment they need or prefer). Workstream 1: We will look at 11 GP surgeries across England, Scotland and Wales. We have selected a variety of sites: urban and rural, serving a range of different communities. Each surgery has a different approach to technology. A researcher from our team will work alongside surgery staff to learn what methods and technologies each practice uses to deliver care. They will gather information (mostly qualitative) about how different technological solutions are playing out over time. Workstream 2: Many people experience barriers to accessing care when it is done through technology. This could be because they lack understanding of how to do it, don’t have the right equipment, can’t afford data, or other reasons. We will ask patients about their experiences and work with them and staff to develop ideas about how to overcome barriers. Workstream 3: We will take what we have learnt in Workstreams 1 and 2 to make suggestions to inform national stakeholders and to influence policymakers. Patients and members of the public helped shape the research design. They continue to help guide our research by reading our reports, giving us their opinions and advising on how best to share our research so everyone can benefit from what we have learnt. Our governance panel is chaired by a member of the public.

Autres résumés

Type: plain-language-summary (eng)
The pandemic required general practices to introduce remote (phone, video and email) consultations. That policy undoubtedly saved lives at the time but there are also clear benefits of face-to-face consultations in some circumstances, and the exact role of remote care still needs to be worked out. Despite best efforts, remote care tends to worsen health inequities (people who were poor or less well educated are less able to access and navigate the system and secure the type of appointment they need or prefer). Workstream 1: We will look at 11 GP surgeries across England, Scotland and Wales. We have selected a variety of sites: urban and rural, serving a range of different communities. Each surgery has a different approach to technology. A researcher from our team will work alongside surgery staff to learn what methods and technologies each practice uses to deliver care. They will gather information (mostly qualitative) about how different technological solutions are playing out over time. Workstream 2: Many people experience barriers to accessing care when it is done through technology. This could be because they lack understanding of how to do it, don’t have the right equipment, can’t afford data, or other reasons. We will ask patients about their experiences and work with them and staff to develop ideas about how to overcome barriers. Workstream 3: We will take what we have learnt in Workstreams 1 and 2 to make suggestions to inform national stakeholders and to influence policymakers. Patients and members of the public helped shape the research design. They continue to help guide our research by reading our reports, giving us their opinions and advising on how best to share our research so everyone can benefit from what we have learnt. Our governance panel is chaired by a member of the public.

Identifiants

pubmed: 37881300
doi: 10.3310/nihropenres.13289.1
pmc: PMC10593351
doi:

Types de publication

Journal Article

Langues

eng

Pagination

46

Informations de copyright

Copyright: © 2022 Greenhalgh T et al.

Déclaration de conflit d'intérêts

No competing interests were disclosed.

Références

Syst Rev. 2017 Jul 3;6(1):128
pubmed: 28673333
BMJ. 2018 Jul 31;362:k3216
pubmed: 30065009
J Med Internet Res. 2021 Oct 7;23(10):e31374
pubmed: 34516389
Postgrad Med. 2020 Jan;132(1):7-16
pubmed: 31570072
Br J Gen Pract. 2021 Feb 25;71(704):e166-e177
pubmed: 33558332
Br J Gen Pract. 2021 May 27;71(707):e423-e431
pubmed: 33824162
Int J Med Inform. 2013 Nov;82(11):e251-68
pubmed: 21481635
Br J Gen Pract. 2018 Apr;68(669):e293-e300
pubmed: 29378697
Lancet. 2014 Nov 22;384(9957):1859-1868
pubmed: 25098487
BJGP Open. 2021 Oct 26;5(5):
pubmed: 34257067
BJGP Open. 2020 Aug 25;4(3):
pubmed: 32487520
Br J Gen Pract. 2019 May;69(682):e321-e328
pubmed: 31015225
Cochrane Database Syst Rev. 2020 Mar 26;3:CD011942
pubmed: 32216074
Br J Gen Pract. 2020 Oct 1;70(699):485-486
pubmed: 33004362
J Am Med Inform Assoc. 2018 Aug 1;25(8):1080-1088
pubmed: 29788380
J Med Internet Res. 2020 Nov 12;22(11):e19375
pubmed: 33035177
Med Humanit. 2019 Sep;45(3):247-257
pubmed: 29954854
Br J Gen Pract. 2019 Aug 29;69(686):e586-e594
pubmed: 31160368
Int J Med Inform. 2020 Sep;141:104228
pubmed: 32683311
BMJ Qual Saf. 2022 Mar 8;:
pubmed: 35260414
Lancet Oncol. 2020 Aug;21(8):1000-1002
pubmed: 32702312
Lancet Oncol. 2020 Aug;21(8):1035-1044
pubmed: 32702311
Lancet. 2016 Jun 4;387(10035):2323-2330
pubmed: 27059888
J Health Serv Res Policy. 2013 Oct;18(4):209-14
pubmed: 23945677
Work. 2021;70(2):395-403
pubmed: 34633337
BMJ. 2020 Sep 28;370:m3709
pubmed: 32988832
BMJ. 2012 Jun 19;344:e4152
pubmed: 22718915
Br J Gen Pract. 2018 Jan;68(666):e1-e8
pubmed: 29109115
Br J Gen Pract. 2019 Aug 29;69(686):e595-e604
pubmed: 31262846
Lancet. 1971 Feb 27;1(7696):405-12
pubmed: 4100731
BMJ Open. 2019 Feb 27;9(2):e026048
pubmed: 30814114
Br J Gen Pract. 2021 Jul 29;71(709):e574-e582
pubmed: 33630749
BJGP Open. 2021 Jun 30;5(3):
pubmed: 33712502
BMJ. 2021 Feb 24;372:n264
pubmed: 33627324
BMJ Open. 2018 Mar 19;8(3):e019966
pubmed: 29555817
Br J Gen Pract. 2021 Jul 29;71(709):344-345
pubmed: 34326075
BMC Health Serv Res. 2013 Apr 05;13:128
pubmed: 23561005
Br J Gen Pract. 2022 Apr 28;72(718):e351-e360
pubmed: 35256385
J Med Internet Res. 2016 Apr 14;18(4):e75
pubmed: 27080852
Br J Gen Pract. 2020 May 28;70(695):295
pubmed: 32467208
BMJ Open. 2019 Aug 1;9(8):e027743
pubmed: 31375610
J Allergy Clin Immunol Pract. 2019 Jan;7(1):199-216.e11
pubmed: 30055283
Cureus. 2020 Aug 5;12(8):e9573
pubmed: 32913690
Br J Gen Pract. 2020 Dec 28;71(702):e1-e9
pubmed: 33318086
J Med Internet Res. 2020 Jun 16;22(6):e18203
pubmed: 32543441
Br J Gen Pract. 2020 Nov 26;70(701):609-610
pubmed: 33243917
BMC Fam Pract. 2020 Dec 13;21(1):269
pubmed: 33308161
Br J Gen Pract. 2016 Jul;66(648):e460-6
pubmed: 27215571
Br J Gen Pract. 2020 May 28;70(695):270-271
pubmed: 32393503
Future Healthc J. 2017 Oct;4(3):189-192
pubmed: 31098469
BJPsych Open. 2020 Dec 10;7(1):e15
pubmed: 33298229
J Telemed Telecare. 2010;16(4):215-20
pubmed: 20511579
Milbank Q. 2004;82(4):581-629
pubmed: 15595944
BJGP Open. 2020 May 1;4(1):
pubmed: 32184212
BMC Med Inform Decis Mak. 2016 Sep 15;16(1):120
pubmed: 27630020
Future Healthc J. 2021 Mar;8(1):e85-e91
pubmed: 33791483
Br J Gen Pract. 2020 Aug 27;70(698):455
pubmed: 32855139
BJGP Open. 2020 May 1;4(1):
pubmed: 32019774
Front Digit Health. 2021 Dec 20;3:754319
pubmed: 34988546
NIHR Open Res. 2022 Nov 29;2:47
pubmed: 36814638
J Med Internet Res. 2020 Nov 9;22(11):e23482
pubmed: 33031045
Front Digit Health. 2021 Aug 13;3:726095
pubmed: 34713199
Br J Gen Pract. 2020 Jul 30;70(697):e540-e547
pubmed: 32661009
Qual Saf Health Care. 2006 Oct;15(5):307-10
pubmed: 17074863
PLoS One. 2014 Sep 04;9(9):e105040
pubmed: 25188322
J Epidemiol Community Health. 2020 Nov;74(11):964-968
pubmed: 32535550
Lancet. 2009 Sep 26;374(9695):1105-12
pubmed: 19782876
Med Humanit. 2021 Sep;47(3):292-301
pubmed: 33782180

Auteurs

Trisha Greenhalgh (T)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, OX2 6GG, UK.

Sara E Shaw (SE)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, OX2 6GG, UK.

Anica Alvarez Nishio (A)

Independent Lay Adviser, London, UK.

Amy Booth (A)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, OX2 6GG, UK.

Richard Byng (R)

University of Plymouth, Plymouth, UK.

Aileen Clarke (A)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, OX2 6GG, UK.

Francesca Dakin (F)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, OX2 6GG, UK.

Roz Davies (R)

Thrive by Design, Leeds, UK.

Stuart Faulkner (S)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, OX2 6GG, UK.

Nina Hemmings (N)

Nuffield Trust, London, UK.

Laiba Husain (L)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, OX2 6GG, UK.

Asli Kalin (A)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, OX2 6GG, UK.

Emma Ladds (E)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, OX2 6GG, UK.

Lucy Moore (L)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, OX2 6GG, UK.

Rebecca Rosen (R)

Nuffield Trust, London, UK.

Sarah Rybczynska-Bunt (S)

University of Plymouth, Plymouth, UK.

Joseph Wherton (J)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, OX2 6GG, UK.

Sietse Wieringa (S)

Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, OX2 6GG, UK.
Centre for Sustainable Health Education, University of Oslo, Oslo, Norway.

Classifications MeSH